Share this story:

Company Update: Koios Beverage Enhancing Its Production Capacity



Koios Beverage Corp.

DENVER, Colorado and VANCOUVER, British Columbia - TheNewswire - November 24, 2023 - Koios Beverage Corp. (CSE:FIT) (OTC:FITS) (the "Company" or "Koios") announces that amidst a period of unprecedented challenges, including persistent supply chain disruptions and value chain complexities, that it has steadfastly navigated the turbulent waters of the global market. These obstacles have tested our resolve and honed our strategic agility, as we've adapted to maintain continuity and quality in our operations. Despite these hurdles, our outlook remains unequivocally optimistic. As we look to the horizon, 2024 stands as a beacon of growth and opportunity. Koios is not only emerging from these trials stronger but also more equipped to capitalize on the potential that the future holds.

 

Building on our momentum, the Company is excited to announce a significant advancement in our production capabilities. We have transitioned the majority of our production to PepsiCo's bottling facilities, a move made possible by our increased volume and growth trajectory. This strategic shift not only allows us to scale up with confidence.  We have taken deliberate steps to fortify this partnership, recognizing the immense value that such an alliance brings to our operations. Together, we are setting new benchmarks in efficiency and production excellence, poised to meet the rising demand for our products.

 

In a strategic leap forward, Koios is proud to declare a substantial reduction in operational costs.  By leveraging PepsiCo’s Bottling extensive network and supply chain expertise, we have significantly streamlined our production process. This pivotal partnership is a keystone in our efforts to enhance efficiency and reduce expenses, ensuring that we can deliver our products more effectively than ever before. Our collaboration with PepsiCo is not just a testament to our growth but a catalyst for continued cost optimization and value creation across our operations.

 

The advancements in our production scale, fostered by this partnership, are unlocking new market territories while simultaneously reinforcing our presence in established channels. This expansion is not just a step but a quantum leap towards our unwavering commitment to growth, innovation, and the pursuit of excellence. We stand at the threshold of a new era, ready to deliver on our promise of quality and reach, and to quench the thirst of a growing customer base across the globe.

 

On behalf of the Board of Directors of the Company,

KOIOS BEVERAGE CORP.

“Chris Miller”

 

Chris Miller, CEO, and Director

 

For further information, please contact:

 

Mt. Zion Market Ventures

Jacob Slade

856-685-8022

mtzionmarketventures@gmail.com

 

THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

 

About Koios Beverage Corp.

The Company is an emerging functional beverage company which has an available distribution network of more than 5,100 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels, and neural connections in the brain.

Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production, and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential outcomes from our relationship with PepsiCo Bottling to reduce the Company’s operational costs by leveraging PepsiCo's extensive bottling network and supply chain expertise, to significantly streamline the Company’s production process and the overall performance of the functional beverage market. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.

The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual's health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.

 

This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.